301 results on '"Mpoudi-Ngole, Eitel"'
Search Results
2. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaounde, Cameroon
3. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
4. Extensive Survey and Analysis of Factors Associated with Presence of Antibodies to Orthoebolaviruses in Bats from West and Central Africa
5. Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
6. Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015-2017
7. Emergence of Unique Primate T-Lymphotropic Viruses among Central African Bushmeat Hunters
8. African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum
9. Detection of DNA of filariae closely related to Mansonella perstans in faecal samples from wild non-human primates from Cameroon and Gabon
10. Exposure to Wild Primates among HIV-infected Persons - Volume 13, Number 10—October 2007 - Emerging Infectious Diseases journal - CDC
11. Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon
12. Extensive survey and analysis of factors associated with presence of antibodies to orthoebolaviruses in bats from West and Central Africa
13. Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses
14. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: Implications for vaccine development
15. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
16. Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon
17. Dynamics of antibodies to Ebolaviruses in an Eidolon helvum bat colony in Cameroon
18. Seroprevalence of IgG Antibodies Against Multiple Arboviruses in Bats from Cameroon, Guinea, and the Democratic Republic of Congo
19. Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon
20. Low Levels of Antiretroviral-Resistant HIV Infection in a Routine Clinic in Cameroon That Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second-Line Treatment
21. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial
22. Assessment of gastrointestinal parasites in wild chimpanzees (Pan troglodytes troglodytes) in southeast Cameroon
23. No Difference in Clinical Progression between Patients Infected with the Predominant Human Immunodeficiency Virus Type 1 Circulating Recombinant Form (CRF) 02 _AG Strain and Patients Not Infected with CRF02 _AG, in Western and West-Central Africa: A Four-Year Prospective Multicenter Study
24. Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon
25. Failure to Detect Simian Immunodeficiency Virus Infection in a Large Cameroonian Cohort with High Non-human Primate Exposure
26. Origin of the human malaria parasite Plasmodium falciparum in gorillas
27. Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon
28. Detection of DNA of filariae closely related to Mansonella perstansin faecal samples from wild non-human primates from Cameroon and Gabon
29. Antiretroviral drug resistance and routine therapy, Cameroon
30. Multiplex detection of antibodies to Chikungunya, O’nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo
31. Origin of the human malaria parasite Plasmodium falciparum in gorillas
32. Exposure to nonhuman primates in rural Cameroon
33. Commercial logging and HIV epidemic, rural Equatorial Africa
34. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial
35. Risk to human health from a plethora of Simian immunodeficiency viruses in primate bushmeat. (Research)
36. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients
37. High HIV burden and recent transmission chains in rural forest areas in southern Cameroon, where ancestors of HIV-1 have been identified in ape populations
38. Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage
39. Extensive serological survey of multiple African non-human primate species reveals low prevalence of Immunoglobulin G antibodies to four Ebola virus species
40. Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon
41. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: a four-year prospective multicenter study
42. Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
43. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage
44. HIV and hepatitis C virus coinfection, Cameroon
45. Understanding Ebola virus and other zoonotic transmission risks through human–bat contacts: Exploratory study on knowledge, attitudes and practices in Southern Cameroon
46. Extensive Serological Survey of Multiple African Nonhuman Primate Species Reveals Low Prevalence of Immunoglobulin G Antibodies to 4 Ebola Virus Species
47. Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms
48. Central African hunters exposed to simian immunodeficiency virus
49. Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey
50. Near full-length HIV type 1M genomic sequences from Cameroon
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.